Markets:

Overview

News

Currencies

International

Treasuries

Bayer Ag Ord (OP:BAYZF)

35.38 +0.11 (+0.30%)

Streaming Delayed Price Updated: 10:34 AM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bayer Ag Ord

< Previous 1 2 3 Next >

Bayer’s Asundexian Met Primary Efficacy and Safety Endpoints in Landmark Phase III OCEANIC-STROKE Study in Secondary Stroke Prevention

November 23, 2025

From Bayer

Via Business Wire

U.S. FDA Approves HYRNUO® (sevabertinib) for Previously Treated Patients with HER2-Mutated Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

November 20, 2025

From Bayer

Via Business Wire

Agricultural Conglomerate Bayer Confident In Long-Term Outlook Despite Litigation Risks ↗

November 12, 2025

Bayer's Q3 earnings rose on strong Crop Science and Pharma sales, with CEO Bill Anderson confident in meeting the company's upgraded 2025 guidance.

Via Benzinga

Bayer Launches “Science Delivers” Campaign Celebrating the Transformative Power of Science

November 10, 2025

From Bayer

Via Business Wire

KERENDIA® (finerenone) Meets Primary Endpoint in Phase III Clinical Trial for Adults with Type 1 Diabetes and Chronic Kidney Disease

November 06, 2025

From Bayer

Via Business Wire

Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause

October 24, 2025

From Bayer

Via Business Wire

Late-breaking data from Phase III OCEANIC-STROKE study accepted for presentation at World Stroke Congress 2025

October 21, 2025

From Bayer

Via Business Wire

Bayer Partners with Cornfed Farms to Create First ForwardFarm in Midwest

October 07, 2025

From Bayer

Via Business Wire

One A Day® Unveils Bold New Brand Identity and Platform: “The ONE for you”

October 07, 2025

From Bayer

Via Business Wire

BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease

October 07, 2025

From Bayer

Via Business Wire

Bayer Selects Interpublic as Global Media, Production and Creative Agency Partner for Consumer Health Division

September 29, 2025

From Bayer

Via Business Wire

Bayer to Highlight New Data for KERENDIA® (finerenone) at Heart Failure Society of America (HFSA) Annual Scientific Meeting 2025

September 25, 2025

From Bayer

Via Business Wire

Bayer First Company to Advance Cell Therapy as Well as Gene Therapy Against Parkinson’s Disease

September 22, 2025

From Bayer

Via Business Wire

10 Years of Supporting Rural America: Bayer and Luke Bryan Team Up with Feeding America® to Tackle Hunger with “Take Care, Now” Campaign

September 15, 2025

From Bayer

Via Business Wire

Gadoquatrane New Drug Application Accepted for Review by U.S. FDA

August 27, 2025

From Bayer

Via Business Wire

Monsanto Reaches Agreements in Principle to Resolve Additional PCB Cases at the Sky Valley Education Center

August 18, 2025

From Bayer

Via Business Wire

Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market

August 15, 2025

From Bayer

Via Business Wire

OTC Markets Group Welcomes Bayer AG to OTCQX

May 23, 2025

From OTC Markets

Via GlobeNewswire

Bayer Shares Fall 7% As US Court Reconsiders Monsanto PCB Exposure Case ↗

October 09, 2024

German life sciences giant Bayer saw its shares drop by over 7% on Wednesday following a US court’s decision to review a case against Monsanto, a subsidiary acquired by Bayer in 2018.

Via Talk Markets

Futures Rally Fizzles As Dollar, Yields And Oil Slump ↗

August 17, 2024

US equity futures erased earlier gains and were trading with modest losses as the dollar, oil, and yields all slumped entering the US session.

Via Talk Markets

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer ↗

July 25, 2024

Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe.

Via Benzinga

Topics Lawsuit

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M ↗

June 05, 2024

Pennsylvania judge cuts Bayer's $2.25 billion Roundup verdict to $400 million. Both Bayer and plaintiff plan appeals in the ongoing cancer litigation.

Via Benzinga

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February ↗

May 24, 2024

Cencora reports a cyberattack exposing sensitive medical information, including patient names, addresses, birth dates, diagnoses, and medications.

Via Benzinga

Topics Data Breach

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval ↗

May 17, 2024

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

Via Benzinga

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned ↗

May 02, 2024

Bayer's Monsanto unit secures a significant legal victory as Washington state appeals court overturns $185 million verdict over chemical contamination. This highlights broader legal battles over PCBs...

Via Benzinga

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant ↗

March 19, 2024

Bayer's Phase 3 study OASIS 3 findings on elinzanetant, a promising non-hormonal treatment for menopausal hot flashes. Results show significant reduction in symptoms over 12 weeks, marking a potential...

Via Benzinga

German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits ↗

March 14, 2024

Bayer contemplates Texas Two-Step bankruptcy to tackle Roundup lawsuits in the US amid mounting jury verdicts. Learn about the controversial tactic and its potential implications.

Via Benzinga

Topics Bankruptcy Lawsuit

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges ↗

March 05, 2024

Bayer charts strategic course amid structural evaluation. CEO Bill Anderson addresses group's challenges, prioritizing performance and flexibility. The company's focus and fiscal outlook for 2024.

Via Benzinga

What's Going On With BridgeBio Pharma Stock On Monday? ↗

March 04, 2024

BridgeBio Pharma partners with Bayer on acoramidis for ATTR-CM in Europe. $310 million deal, FDA application accepted.

Via Benzinga

Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial ↗

January 30, 2024

Follow the landmark Australian Roundup lawsuit against Bayer. Closing arguments in class action alleging Roundup's link to cancer.

Via Benzinga

Topics Lawsuit

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.